Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Alcohol Screening in an Ethnically Diverse Sample of Adolescents in Primary Care

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Valley Community Clinic
UPMC St. Margaret Family Health Centers
Information provided by (Responsible Party):
RAND
ClinicalTrials.gov Identifier:
NCT01797835
First received: February 21, 2013
Last updated: April 22, 2016
Last verified: April 2016
  Purpose
Screening youth in the primary care setting is one way to identify adolescents who may be at-risk for future alcohol problems. The current study tests the new NIAAA screening guide questions, which ask about friend and adolescent drinking, to see how well these questions work to predict subsequent alcohol use, problems, and involvement in other risk behaviors, such as sexual risk-taking and delinquency. In addition, the investigators plan to provide a brief motivational intervention for some at-risk teens and see whether alcohol use differs for those teens who receive the intervention and those teens who receive enhanced usual care. The results of this study have the potential to significantly impact the standard of care for identifying and intervening with at- risk youth in primary care settings.

Condition Intervention
Alcohol Use
Drug Use
Behavioral: CHAT brief MI intervention
Behavioral: usual care

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Alcohol Screening in an Ethnically Diverse Sample of Adolescents in Primary Care

Resource links provided by NLM:


Further study details as provided by RAND:

Primary Outcome Measures:
  • Alcohol use [ Time Frame: Past 30 days ] [ Designated as safety issue: No ]
    in the past 30 days: Number of times used alcohol, number of drinks, number of heavy drinking days


Secondary Outcome Measures:
  • marijuana use [ Time Frame: past 30 days ] [ Designated as safety issue: No ]
    number of times used marijuana in the past 30 days


Enrollment: 1573
Study Start Date: March 2013
Estimated Study Completion Date: August 2017
Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Usual Care
Youth in usual care will receive screening for alcohol and drug use. Those youth who are at risk will have a chance to talk to their provider about their use. They will also receive an informational brochure.
Behavioral: usual care
Youth receive a brochure with information on AOD use.
Experimental: CHAT brief MI intervention
Youth in CHAT will receive screening for alcohol and drug use. Those youth who are at risk will have a chance to talk to their provider about their use. In addition, these youth will CHAT. CHAT is a brief motivational intervention that takes places in the primary care setting. It is a 15-20 minute intervention for adolescents age 12-18 focused on discussing alcohol and drug use. They will also receive a booster call one month later to check in on how they are doing.
Behavioral: CHAT brief MI intervention
CHAT is one 15-20 minute session delivered in a single PC visit and utilizes motivational interviewing with youth to target alcohol and drug use in primary care.

  Eligibility

Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: 1

  • 12-18
  • speak English

Exclusion Criteria:

  • cognitive impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01797835

Locations
United States, California
Valley Community Clinic
North Hollywood, California, United States, 91605
United States, Pennsylvania
UPMC St. Margaret
Pittsburgh, Pennsylvania, United States, 15215
Sponsors and Collaborators
RAND
Valley Community Clinic
UPMC St. Margaret Family Health Centers
Investigators
Principal Investigator: Elizabeth J D'Amico, PhD RAND
  More Information

Responsible Party: RAND
ClinicalTrials.gov Identifier: NCT01797835     History of Changes
Other Study ID Numbers: 1R01AA021786 
Study First Received: February 21, 2013
Last Updated: April 22, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by RAND:
adolescents
intervention
motivational interviewing
alcohol and drug use

Additional relevant MeSH terms:
Ethanol
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on September 30, 2016